La Jolla, CA, United States of America

Cindra A Widrig Opalsky


Average Co-Inventor Count = 5.0

ph-index = 4

Forward Citations = 250(Granted Patents)


Location History:

  • Ottawa, CA (2004)
  • La Jolla, CA (US) (2010 - 2011)

Company Filing History:


Years Active: 2004-2011

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Cindra A Widrig Opalsky: Innovator in Coagulation Assays

Introduction

Cindra A Widrig Opalsky is a notable inventor based in La Jolla, CA (US). She has made significant contributions to the field of medical diagnostics, particularly in coagulation assays. With a total of 4 patents to her name, her work has advanced the capabilities of point-of-care testing.

Latest Patents

One of her latest inventions is a method for assaying coagulation in fluid samples. This invention features a disposable cartridge designed for use at the patient side, enabling traditional coagulation assays on fresh whole blood or blood derivative samples. The cartridge, when used with an electronic analyzer, allows for the metering and quantitative mixing of fluid samples with reagents that activate the coagulation cascade. Additionally, it includes an artificial substrate for thrombin, the enzyme responsible for clot formation. Clot formation is detected using a microfabricated sensor housed within the cartridge, which electrochemically detects the product of the thrombin reaction on the synthetic substrate.

Career Highlights

Cindra has worked with prominent companies in the medical field, including Abbott Point of Care Inc. and i-Stat Corporation. Her experience in these organizations has contributed to her expertise in developing innovative diagnostic solutions.

Collaborations

Some of her notable coworkers include David Opalsky and Imants R Lauks. Their collaboration has likely played a role in the success of her inventions.

Conclusion

Cindra A Widrig Opalsky's contributions to the field of coagulation assays demonstrate her commitment to advancing medical diagnostics. Her innovative inventions continue to impact patient care positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…